Good morning :)
$
₹
Senseonics Holdings, Inc. Common Stock

Senseonics Holdings, Inc. Common Stock

SENS

NASDAQ
Asset Logo

Senseonics Holdings, Inc. Common Stock

SENS

NASDAQ
$9.632.71% (-0.26)
$
₹
$9.632.71% (-0.26)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
Loading...
1D
1W
1M
1Y
5Y
Max

Healthcare

Medical Devices

Small Cap

With a market cap of $509.2M the stock is ranked 3328

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

—
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

5.79
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$-2.24
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

0
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

-225.34%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

—

Analyst Ratings & Forecast
Analyst Ratings & Forecast

Based on 4 analysts' reports

Buy
2 analysts
Hold
1 analyst
Sell
1 analyst

Analysts expect a +39.15% price upside over the next year

Current Price$9.63
Target Price$13.4

Company Profile

Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. Its products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. Its products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.

Peers

Peers

Medline Inc. Class A Common Stock
MDLN
M
P/E Ratio
45.73
45.73
1Y Return
10.75%
10.75%
Buy Reco %
—
—
West Pharmaceutical Services Inc
WST
West Pharmaceutical Services Inc
P/E Ratio
43.47
43.47
1Y Return
37.44%
37.44%
Buy Reco %
92.30
92.30
The Cooper Companies, Inc
COO
The Cooper Companies, Inc
P/E Ratio
58.97
58.97
1Y Return
2.33%
2.33%
Buy Reco %
57.89
57.89
Align Technology Inc
ALGN
Align Technology Inc
P/E Ratio
27.54
27.54
1Y Return
17.76%
17.76%
Buy Reco %
61.11
61.11
MiniMed Group, Inc. Common Stock
MMED
M
P/E Ratio
—
—
1Y Return
16.42%
16.42%
Buy Reco %
—
—

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareMedical Devices

Valuation

Returns

Forecast

StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
Senseonics Holdings, Inc. Common Stock -5.790
Medline Inc. Class A Common Stock45.732.77-
West Pharmaceutical Services Inc43.478.062.66

Price Comparison

Price Comparison

1 Month

1 Year

5 Years

Loading...

Financials

Financials

Income

Balance Sheet

Cash Flow

8
-19.5
14.2
-20.8
11.7
-32.3
14.4
-36.7
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Revenue
Net Income
Financial YearQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Total Revenue5.044.864.268.296.256.648.0914.2511.7114.48
Net Income-18.87-20.28-23.97-15.47-14.25-14.50-19.53-20.82-32.33-36.70
Net Profit Margin-374.02%-416.99%-562.42%-186.52%-227.88%-218.09%-241.26%-146.06%-276.09%-253.43%
See CostsAll values in $ Million

Frequently asked questions

Frequently asked questions

  1. Senseonics Holdings, Inc. Common Stock (SENS) share price today is $9.63 as of September 5, 2026 at 1:30 AM IST. The stock touched a day high of $9.93 and a day low of $9.63.

  2. Senseonics Holdings, Inc. Common Stock stock trades on NASDAQ under the ticker symbol SENS.

  3. Senseonics Holdings, Inc. Common Stock's market capitalization is $509.17M as of September 5, 2026 at 1:30 AM IST.

  4. Senseonics Holdings, Inc. Common Stock's price-to-earnings (P/E) ratio is N/A as of September 7, 2026.

  5. Senseonics Holdings, Inc. Common Stock's price-to-book (P/B) ratio is 5.79 as of September 7, 2026.

  6. Yes, You can buy Senseonics Holdings, Inc. Common Stock shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  7. Indian investors can buy Senseonics Holdings, Inc. Common Stock shares in three steps: 1. Search Senseonics Holdings, Inc. Common Stock on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  8. Since Senseonics Holdings, Inc. Common Stock trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  9. Indian investors can start investing in Senseonics Holdings, Inc. Common Stock (SENS) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 1.0383 shares at the current price of $9.63.

Loading...